Paper Details

Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):

Faculty Members have conducted research related to the Iranian Association of Gastroenterology and Hepatology Position Statement in Management of Inflammatory Bowel Disease by Using Biological Drugs: Expert View; [بیانیه انجمن گوارش و کبد ایران در مورد مصرف داروهای بیولوژیک در بیماری هایالتهابی روده]

Mansoor Rastegarpanah

Mansoor Rastegarpanah

Associate Professor of Clinical Pharmacy

Department Clinical Pharmacy

School of Pharmacy

Tehran University of Medical Sciences

Related Documents

1. Iranian Consensus Guideline for Pharmacotherapy With Biologics and Small Molecules Drugs in Adults With Inflammatory Bowel Diseases, Middle East Journal of Digestive Diseases (2023)

All Documents

1. Iranian Consensus Guideline for Pharmacotherapy With Biologics and Small Molecules Drugs in Adults With Inflammatory Bowel Diseases, Middle East Journal of Digestive Diseases (2023)

2. The Utilization Patterns of Vancomycin, Metronidazole, Ceftriaxone, and Ceftazidime in the Icu Ward of a Public Hospital of Tehran Medical University: A Cross-Sectional Study, Egyptian Pharmaceutical Journal (2020)

3. Developing and Validating a Tool to Evaluate Communication and Patient Counselling Skills of Pharmacy Students: A Pilot Study, Pharmacy Education (2019)

4. Evaluation of Knowledge, Attitude, and Practice About Rational Prescribing and Use of Drugs Among General Practitioners in Tehran City, Iran, Journal of Isfahan Medical School (2018)

5. Assessment of Orthographic Similarity of Drugs Names Between Iran and Overseas Using the Solar Model, Iranian Journal of Public Health (2017)

6. Incidence of Medication Discrepancies and Its Predicting Factors in Emergency Department, Iranian Journal of Public Health (2017)

7. The Establishment of the Drug Naming Committee to Restrict Look-Alike Medication Names in Iran: A Qualitative Study, International Journal of Risk and Safety in Medicine (2017)

8. A Randomized, Double Blinded, Placebo-Controlled Clinical Trial of Silymarin in Ulcerative Colitis, Chinese Journal of Integrative Medicine (2015)